Mustang Bio, Inc.
Here’s whether Mustang Bio, Inc. (MBIO) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: RSI 59 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.87% over 10 days); weak 1-year return of -46.4%; 3-month momentum negative (-27.1%); rising volume on a downtrend (distribution, 2.58x avg). Currently 90.4% off its 52-week high. Score: -5/7.
MBIO is trading below its 200-day MA ($1.10) — a key warning sign the longer-term trend is under pressure. An RSI of 58.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -46.4% compares to +24.4% for SPY (trailed the market by 70.8%). The current 90.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.